A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Non Alcoholic Fatty Liver Disease Patients
Clinical trial NCT04197479 · COMPLETED
Trial details
- NCT number
- NCT04197479
- Sponsor
- Madrigal Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-16
- Primary completion
- 2023-01-06
- Enrollment
- 1343
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.